Literature DB >> 12737194

Optimized detection of respiratory viruses in nasopharyngeal secretions.

M Zavattoni1, E Percivalle, E Cattaneo, M G Revello, M Torsellini, G Gerna.   

Abstract

Nasopharyngeal secretions (NPS) from 121 (110 pediatric) patients with acute respiratory infections were examined for respiratory virus detection by: i) conventional virus isolation in cell cultures (CC) using HEp-2, LLC-MK2, and MDCK cells; ii) rapid virus isolation using shell vial cultures (SVC) of a mixture (MIX) of mink lung epithelial cells (Mv1Lu) and human lung carcinoma (A549) cells in comparison to LLC-MK2 and MDCK cells; iii) direct fluorescent antibody (DFA) assay on NPS cells. A pool of monoclonal antibodies (MAbs) to influenzavirus A and B, parainfluenzavirus types 1 to 3, adenoviruses and respiratory syncytial virus (RSV), as well as single MAbs to the same viruses, were used for virus identification in all three procedures. Results on 101 NPS examined in parallel showed a sensitivity of 89.5%, 73.7%, and 81.6% for CC, SVC, and DFA, respectively, with the relevant negative predictive values of 94.0%, 86.3%, and 90.0%. Specificity and positive predictive values were 100%. However, the combination of DFA and SVC gave best results in terms of sensitivity (94.7%) and negative predictive value (95.5%). Use of the new MIX cell culture system in the SVC procedure enhanced virus detection, while use of the MAb pool allowed prompt identification of negative samples and saving of reagents and time for all three procedures. The combination of DFA and SVC allows diagnosis of the large majority of viral respiratory infections within 48h, while conventional virus isolation on CC may be limited to laboratories involved in research and epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737194

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  9 in total

Review 1.  Role of cell culture for virus detection in the age of technology.

Authors:  Diane S Leland; Christine C Ginocchio
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 2.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

3.  Evaluation of the Alere I influenza A&B nucleic acid amplification test by use of respiratory specimens collected in viral transport medium.

Authors:  J Jeremiah Bell; Rangaraj Selvarangan
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

4.  Prevalence and correlation of infectious agents in hospitalized children with acute respiratory tract infections in Central China.

Authors:  Jia Liu; Hongwu Ai; Ying Xiong; Fu Li; Zhou Wen; Weiyong Liu; Tongya Li; Kai Qin; Jianguo Wu; Yingle Liu
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

5.  Monoclonal antibodies versus reverse transcription-PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital.

Authors:  Francesca Rovida; Elena Percivalle; Maurizio Zavattoni; Maria Torsellini; Antonella Sarasini; Giulia Campanini; Stefania Paolucci; Fausto Baldanti; M Grazia Revello; Giuseppe Gerna
Journal:  J Med Virol       Date:  2005-02       Impact factor: 2.327

6.  Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients.

Authors:  Giuseppe Gerna; Patrizio Vitulo; Francesca Rovida; Daniele Lilleri; Carlo Pellegrini; Tiberio Oggionni; Giulia Campanini; Fausto Baldanti; M Grazia Revello
Journal:  J Med Virol       Date:  2006-03       Impact factor: 2.327

7.  A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines.

Authors:  Jens-Peter Gregersen
Journal:  Vaccine       Date:  2008-04-15       Impact factor: 3.641

8.  A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine.

Authors:  Jens-Peter Gregersen
Journal:  Vaccine       Date:  2008-04-18       Impact factor: 3.641

9.  Feasibility of Point-of-Care Testing for Influenza Within a National Primary Care Sentinel Surveillance Network in England: Protocol for a Mixed Methods Study.

Authors:  Simon de Lusignan; Uy Hoang; Harshana Liyanage; Ivelina Yonova; Filipa Ferreira; Javier Diez-Domingo; Tristan Clark
Journal:  JMIR Res Protoc       Date:  2019-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.